share_log

中关村(000931.SZ):下属公司山东华素盐酸贝尼地平片(4mg、2mg)通过一致性评价

Zhongguancun (000931.SZ): Shandong Huasu, a subsidiary company, benidipine hydrochloride tablets (4mg, 2mg) passed the consistency evaluation

Gelonghui Finance ·  Dec 25, 2023 02:47

Gelonghui, December 25 | Zhongguancun (000931.SZ) announced that recently, Shandong Huasu Pharmaceutical Co., Ltd. (Shandong Huasu), a subsidiary of the company, received the “Drug Supplement Application Approval Notice” (Notice No.: 2023B06429, 2023B06430) approved and issued by the State Drug Administration and learned that “benidipine hydrochloride tablets” (specifications: 4mg, 2mg) produced by Huasu Shandong have passed the consistent evaluation of the quality and efficacy of generic drugs.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment